Back

Targeted inference to identify drug repositioning candidates in the Danish health registries

Jung, A. W.; Louloudis, I.; Brunak, S.; Mortensen, L. H.

2024-08-12 epidemiology
10.1101/2024.08.12.24311869 medRxiv
Show abstract

Electronic health records can be used to track diagnoses and drug prescriptions in large heterogeneous populations over time. Coupled with recent advances in causal inference from observational data, these records offer new opportunities to emulate clinical trials and identify potential targets for drug repositioning. Here, we run a hypothesis generating cohort study of Danes aged 50 to 80 years from 2001 to 2015 (n = 2,512,380), covering a total of 23,371,354 years of observations. We examine prescription drugs at ATC level-4 and their effect on 9 major disease outcomes. Using Bayesian time-varying Cox regression and longitudinal minimum loss estimation, our analysis successfully reproduces known drug-disease associations from clinical trials, such as the reduction in the 3-year absolute risk of death associated with Statins (ATC:C10AA) -0.8% (95% CI =[-1.2%, -0.5%]) and -0.8% (95% CI =[-1.3%, -0.2%]) for females and males, respectively. Additionally, we discovered novel associations that suggest potential repositioning opportunities. For instance, Statins were associated with a reduction in the 3-year absolute risk of dementia by -0.3% (95% CI =[-0.5%, -0.1%]) for females and -0.2% (95% CI =[-0.4%, 0.1%]) for males. Furthermore, Biguanides (ATC:P01BB) stands out as a particularly interesting candidate with absolute risk reductions across various outcomes. In total, we identified 76 potential drug-disease pairs for further investigation. However, it should be stressed that the emulation of clinical trials here is solely of hypothesis generating nature and identified effects need to be corroborated with additional evidence, preferably from RTCs, as the risk of confounding by indication in this study is substantial. In summary, this study provides a large-scale screen of prescribed drugs and their effect on major debilitating disease in the Danish health registries. This provides an additional source of information that can be used in the search for possible repositioning candidates.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Communications Medicine
85 papers in training set
Top 0.1%
8.3%
2
Nature Human Behaviour
85 papers in training set
Top 0.3%
6.7%
3
Nature Communications
4913 papers in training set
Top 30%
6.2%
4
BMC Medicine
163 papers in training set
Top 0.8%
4.8%
5
npj Digital Medicine
97 papers in training set
Top 0.9%
4.8%
6
International Journal of Epidemiology
74 papers in training set
Top 0.4%
4.8%
7
Scientific Reports
3102 papers in training set
Top 25%
4.8%
8
PLOS ONE
4510 papers in training set
Top 36%
3.9%
9
eLife
5422 papers in training set
Top 23%
3.9%
10
PLOS Computational Biology
1633 papers in training set
Top 11%
3.2%
50% of probability mass above
11
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 0.2%
3.0%
12
Genome Medicine
154 papers in training set
Top 3%
2.8%
13
Science Advances
1098 papers in training set
Top 10%
2.6%
14
Nature Genetics
240 papers in training set
Top 3%
2.1%
15
PLOS Genetics
756 papers in training set
Top 7%
2.1%
16
Frontiers in Pharmacology
100 papers in training set
Top 2%
2.1%
17
Pharmacoepidemiology and Drug Safety
13 papers in training set
Top 0.2%
1.9%
18
European Journal of Epidemiology
40 papers in training set
Top 0.3%
1.8%
19
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.6%
20
Bioinformatics Advances
184 papers in training set
Top 3%
1.5%
21
Genetic Epidemiology
46 papers in training set
Top 0.5%
1.3%
22
The Lancet Digital Health
25 papers in training set
Top 0.7%
1.2%
23
eBioMedicine
130 papers in training set
Top 3%
0.9%
24
British Journal of Clinical Pharmacology
21 papers in training set
Top 0.6%
0.8%
25
iScience
1063 papers in training set
Top 33%
0.7%
26
PLOS Biology
408 papers in training set
Top 20%
0.7%
27
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.7%
28
Science Translational Medicine
111 papers in training set
Top 7%
0.7%
29
Scientific Data
174 papers in training set
Top 3%
0.7%
30
Aging Cell
144 papers in training set
Top 4%
0.6%